DISCLOSURE OF INTERESTS:
All of the authors reported funding from the Eunice Kennedy
Shriver National Institute of Child Health and Human Development
(NICHD) and the National Institutes of Health Office of Research on
Women’s Health and that Boston Scientific Corporation provided partial
support through a research grant to the Pelvic Floor Disorders Network
(PFDN) Data Coordinating Center, RTI International.
- Dr. Moalli reported serving as a consultant to Hologic Inc and
receiving research support from the NICHD.
- Dr. Abramowitch reported receiving research support from the
NICHD and Renovia Inc.
- Dr. Rardin reported receiving research support from Solace
Therapeutics, Pelvalon, Foundation for Female Health Awareness, and
the NICHD.
- Dr. Hahn reported receiving research support from General
Electric and serving as a consultant to HealthLytix.
- No other disclosures were reported.
CONTRIBUTION TO AUTHORSHIP :
MGG, PI, and BC had full access to all of the data in the study and take
responsibility for the integrity of the data and the accuracy of the
data analysis.
- PAM, DM, and MGG were involved in project administration and
supervision.
- PAM, SDA, DHL, IM, CRR, HSH, MEH, and MGG had a role in
conceptualization, methodology, and funding acquisition.
- PAM, STB, SDA, DHL, IM, CRR, HSH, MEH, PI, BC, MGG contributed to the
data collection and analysis.
- All contributing authors were involved in drafting, revising, and
final approval of the manuscript.